Pituitary desensitization to gonadotropin-releasing hormone increases abdominal adiposity in hyperandrogenic anovulatory women

Fertility and Sterility

Volumn 70, Issue 1, 1998, Pages 94-101

  Dumesic, Daniel A ^a   Abbott, David H ^b   Eisner, Joel R ^b   Herrmann, Rebekah R ^b   Reed, Judd E ^b   Welch, Timothy J ^b   Jensen, Michael D ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Androgens; Body fat distribution; Hyperandrogenic anovulation

Indexed keywords

GONADORELIN DERIVATIVE; LEUPRORELIN;

ADULT; ANOVULATION; ANTHROPOMETRY; ARTICLE; BODY FAT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HYPERANDROGENISM; INTRAMUSCULAR DRUG ADMINISTRATION; LIPOLYSIS; PRIORITY JOURNAL;

ABDOMEN; ADIPOSE TISSUE; ADULT; ANOVULATION; ANTHROPOMETRY; BODY COMPOSITION; BODY MASS INDEX; DENSITOMETRY, X-RAY; FEMALE; GONADAL STEROID HORMONES; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYPERANDROGENISM; PITUITARY GLAND; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032124873     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00098-3     Document Type: Article

References (25)

1. 1. Coppack SW, Jensen MD, Miles JM. In vivo regulation of lipolysis in humans. J Lipid Res 1994;35:177-93.
2. 2. Seidell JC, Bjorntorp P, Sjostrom L, Kvist H, Sannerstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 1990;39:897-901.
3. 3. Rebuffe-Scrive M, Marin P, Bjorntorp P. Effect of testosterone on abdominal adipose tissue in men. Int J Obes 1991;15:791-5.
4. 4. Marin P, Oden B, Bjorntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab 1995;80:239-43.
5. 5. Marin P, Lonn L, Andersson B, Oden B, Olbe L, Bengtsson BA, et al. Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: effects of testosterone. J Clin Endocrinol Metab 1996;81:1018-22.
6. 6. Marin P, Holmang S, Gustafsson C, Jonsson L, Kvist H, Elander A. Androgen treatment of abdominally obese men. Obes Res 1993;1:245-51.
7. 7. Rebuffe-Scrive M, Cullberg G, Lundberg PA, Lindstedt G, Bjorntorp P. Anthropometric variables and metabolism in polycystic ovary disease. Horm Metab Res 1989;21:391-7.
8. 8. Diamanti-Kandarakis E, Mitrakou A, Hennes MMI, Platanissiotis D, Kaklas N, Spina J, et al. Insulin sensitivity and antiandrogen therapy in women with polycystic ovary syndrome. Metabolism 1995;44:525-31.
9. 9. Van der Kooy K, Leenen R, Seidell JC, Deurenberg P, Droop A, Bakker CJG. Waist-hip ratio is a poor predictor of changes in visceral fat. Am J Clin Nutr 1993;57:327-33.
10. 10. Dumesic DA, Matteri RL. Obesity affects circulating estradiol levels of premenopausal hirsute women receiving leuprolide acetate depot. Int J Fertil 1993;38:139-46.
11. 11. Dewailly D, Vantyghem-Haudiquet MC, Sainsard C, Buvat J, Cappoen JP, Ardaens K, et al. Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency. J Clin Endocrinol Metab 1986;63:418-23.
12. 12. Jensen MD, Kanaley JA, Reed JE, Sheedy PF. Measurement of abdominal and visceral fat with computed tomography and dual energy x-ray absorptiometry. Am J Clin Nutr 1995;61:274-8.
13. 13. Wild RA. Hyperandrogenism: implications for cardiovascular, endometrial, and breast disease. In: Adashi EY, Rock JA, Rosenwaks Z, editors. Reproductive endocrinology, surgery, and technology. Philadelphia: Lippincott-Raven Publishers, 1996:1617-34.
14. 14. Sokal RR, Rohlf FJ. Biometry, the principles and practice of statistics in biological research. 3rd ed. New York: WH Freeman and Co., 1995.
15. 15. Abate N, Garg A. Heterogeneity in adipose tissue metabolism: causes, implications and management of regional adiposity. Prog Lipid Res 1995;34:53-70.
16. 16. Xu X, De Pergola G, Bjorntorp P. The effects of androgens on the regulation of lipolysis in adipose precursor cells. Endocrinology 1990; 126:1229-34.
17. 17. Holte J, Bergh T, Berne C, Berglund L, Lithell H. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal insulin tolerance. J Clin Endocrinol Metab 1994;78:1052-8.
18. 18. Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S. A novel technique for the determination of body fat by computed tomography. Int J Obes 1983;7:437-45.
19. 19. Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996;81:3299-306.
20. 20. Reynisdottir S, Ellerfeldt K, Wahrenberg H, Lithell H, Arner P. Multiple lipolysis defects in the insulin resistance (metabolic) syndrome. J Clin Invest 1994;93:2590-9.
21. 21. Ek I, Arner P, Bergqvist A, Carlstrom K, Wahrenberg H. Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: a possible link to insulin resistance. J Clin Endocrinol Metab 1997;82:1147-53.
22. 22. Rebuffe-Scrive M, Enk L, Crona N, Lonnroth P, Abrahamsson L, Smith U, et al. Fat cell metabolism in different regions in women. Effects of menstrual cycle, pregnancy and lactation. J Clin Invest 1985;75:1973-6.
23. 23. Rebuffe-Scrive M, Eldh J, Hafstrom L-O, Bjorntorp P. Metabolism of mammary, abdominal and femoral adipocytes in women before and after menopause. Metabolism 1986;35:792-7.
24. 24. Rebuffe-Scrive M, Lonnroth P, Marin P, Wesslau C, Bjorntorp P, Smith U. Regional adipose tissue metabolism in men and postmenopausal women. Int J Obes 1987;11:347-55.
25. 25. Rebuffe-Scrive M, Basdevant A, Guy-Grand B. Effect of local application of progesterone on human adipose tissue lipoprotein lipase. Horm Metab Res 1983;15:566.